Friday 26 April 2024
Internal Reference Number: FOI_6464
Date Request Received: 08/02/2022 00:00:00
Date Request Replied To: 01/03/2022 00:00:00
This response was sent via: By Email
Request Summary: Biologic drugs in Gastroenterology
Request Category: Companies
| Question Number 1: Please provide the numbers of patients treated in the last 3 months by the Gastroenterology department for any medical condition, and if possible, for Ulcerative Colitis, with the following biologic drugs: See attached | |
| Answer To Question 1: Treatments Total Gastroenterology Patients Adalimumab - Humira 6 Adalimumab Biosimilar 63 Filgotinib 0 Golimumab 2 Infliximab - Remicade 7 Infliximab Biosimilar 117 Ozanimod 0 Tofacitinib 1 Ustekinumab 36 Vedolizumab 37 No access to indications so cannot identify UC patients To accompany this answer to question 1 please also see the documents listed below:  FOI 6464 - Table.docx | |
| Please see Attachments: | |
| To return to the list of all the FOI requests please click here | |
Our staff at Salisbury District Hospital have long been well regarded for the quality of care and treatment they provide for our patients and for their innovation, commitment and professionalism. This has been recognised in a wide range of achievements and it is reflected in our award of NHS Foundation Trust status. This is afforded to hospitals that provide the highest standards of care.
